The data is not available in the format requested as the Scottish Breast Screening Programme (SBSP) is delivered from six screening centres, each covering a designated population. The SBSP should offer an appointment to women within 36 months of their previous screening episode.

On average, the West and South West screening centres are offering women aged 53-70 a screening appointment within 39 months of their last screen.

The National Screening Oversight, Scottish Screening Committee and Breast Screening Programme Board (BSPB) continue to work with health boards to increase the number of available appointments, including through deploying additional mobile breast screening units and providing additional appointments during evenings and at weekends.

It should be noted that this data is unpublished management data that has not been subject to the standard quality checks that are applied to statistical publications.

The data is not available in the format requested as the Scottish Breast Screening Programme (SBSP) is delivered from six screening centres, each covering a designated population. It should be noted that the data provided below is management information that has not been subject to the quality checks that are normally applied on a statistical publication.

For women aged 53-70 years who were screened between 1st April 2020 and 31st January 2021, the average interval between screening episodes was 41 months across Scotland. The average interval between screening episodes across each screening centre was as follows:

East – 46 months

North – 40 months

North East – 42 months

South East – 41 months

West – 38 months

South West – 39 months

As we anticipate a decision from the UK National Screening Committee (NSC) in the coming months, we have no current plans to expedite this. This is a complex matter and it is important that time is taken to evaluate all available evidence. The Scottish Government has, however, provided funding to the University of Edinburgh to support an exploratory piece of research into the feasibility of the introduction of lung health checks within Scotland and it is hoped that the findings will support the evidence base being considered by the NSC.

I refer the member to the answer to question S6W-05600 on 10 January 2022. All answers to written Parliamentary Questions are available on the Parliament's website, the search facility for which can be found at https://www.parliament.scot/chamber-and-committees/written-questions-and-answers

It continues to reflect our latest position.

We have established a process for individuals who have received their coronavirus vaccinations outwith Scotland which allows for them to upload official proof of vaccination from an approved country to their Scottish Vaccination Record through NHS Inform . This will allow those who have been vaccinated within the UK or internationally to receive a combined fully vaccinated status to show for travel and domestic purposes.

The Scottish Ministers accept the summary judgement in the English court proceedings brought by CMAL against insurer HCCI.

I refer the member to the answer to question S6W-06441 on 28 February 2022. All answers to written Parliamentary Questions are available on the Parliament's website, the search facility for which can be found at https://www.parliament.scot/chamber-and-committees/written-questions-and-answers

The information requested is not collected centrally. There are a number of factors which clinicians will use to determine individual suitability for closed loop systems and other diabetes technologies.

We expect clinicians and NHS Boards to follow all relevant national clinical guidelines when assessing the most appropriate treatment for someone living with diabetes, including the use of closed loop systems.

The Scottish Diabetes Survey provides an annual summary of key issues and trends in diabetes care and treatment in Scotland, including the numbers of people accessing diabetes technologies. The 2020 Survey was published in January of this year and can be found by following link: https://www.diabetesinscotland.org.uk/publications/#survey-docs.

Our Diabetes Improvement Plan contains a commitment to increase access to diabetes technologies such as closed loop systems for everyone who would benefit from these life changing therapies. The closed loop system is a new technology and the additional £14.6 million of funding that we have made available to NHS Boards in 2022 will help with its introduction, as well as increase access to existing technologies such as insulin pumps and continuous glucose monitors.

Our Diabetes Improvement Plan contains specific commitments to support increased access to diabetes technologies, with significant focus on equity of access to care and services. We expect clinicians and NHS Boards to follow all relevant clinical guidelines and provide anyone with type 1 diabetes with a closed loop system, if they are clinically suitable.

Whenever someone is issued with any diabetes technology device, including closed loop systems, specific training and education on how to use it will be provided by a diabetes specialist nurse. Training is given to the individual and/or their carer, who will also need to confirm that they are competent in its use.

Patients are also encouraged to contact their diabetes clinical team if they have any concerns around the device’s function and its use.

Patient education is also a key priority of our Diabetes Improvement Plan Refresh, published in February 2021.